home / stock / blco / blco quote
Last: | $14.66 |
---|---|
Change Percent: | -0.27% |
Open: | $14.7 |
Close: | $14.66 |
High: | $14.73 |
Low: | $14.64 |
Volume: | 82,921 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$14.66 | $14.7 | $14.66 | $14.73 | $14.64 | 82,921 | 07-03-2024 |
$14.66 | $14.51 | $14.66 | $14.74 | $14.51 | 333,379 | 07-02-2024 |
$14.59 | $14.58 | $14.59 | $14.79 | $14.43 | 407,297 | 07-01-2024 |
$14.52 | $14.75 | $14.52 | $14.915 | $14.41 | 669,515 | 06-28-2024 |
$14.77 | $14.85 | $14.77 | $14.85 | $14.67 | 234,643 | 06-27-2024 |
$14.77 | $14.71 | $14.77 | $14.89 | $14.64 | 261,604 | 06-26-2024 |
$14.89 | $14.93 | $14.89 | $15.04 | $14.83 | 384,482 | 06-25-2024 |
$14.94 | $14.98 | $14.94 | $15.16 | $14.81 | 425,275 | 06-24-2024 |
$14.93 | $15.08 | $14.93 | $15.25 | $14.72 | 740,472 | 06-21-2024 |
$15.09 | $14.71 | $15.09 | $15.25 | $14.55 | 371,798 | 06-20-2024 |
$14.74 | $15.03 | $14.74 | $15.03 | $14.71 | 296,278 | 06-19-2024 |
$14.74 | $15.03 | $14.74 | $15.03 | $14.71 | 296,278 | 06-18-2024 |
$14.94 | $14.9 | $14.94 | $15.065 | $14.81 | 270,170 | 06-17-2024 |
$15.09 | $14.69 | $15.09 | $15.11 | $14.69 | 133,546 | 06-14-2024 |
$14.87 | $14.8 | $14.87 | $14.93 | $14.66 | 191,691 | 06-13-2024 |
$14.9 | $15.23 | $14.9 | $15.23 | $14.9 | 169,665 | 06-12-2024 |
$14.96 | $14.85 | $14.96 | $14.99 | $14.71 | 222,683 | 06-11-2024 |
$15.01 | $15.15 | $15.01 | $15.29 | $15.01 | 111,127 | 06-10-2024 |
$15.32 | $15.31 | $15.32 | $15.72 | $15.21 | 208,006 | 06-07-2024 |
$15.48 | $15.58 | $15.48 | $15.68 | $15.43 | 199,120 | 06-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Bausch + Lomb Corporation Company Name:
BLCO Stock Symbol:
NYSE Market:
Bausch + Lomb Corporation Website:
Events Include Symposium on Patient-Centric Approaches to Dry Eye, Highlighting Breakthroughs in Diagnosis, Treatment and Care Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the pre...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of Bausch + Lomb INFUSE for Astigmatism daily disposable contact lenses. Engineered with a next-generation lens material inf...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of Blink NutriTears, a clinically proven over-the-counter supplement that targets the key root causes of dry eyes, promotes health...